National LTC Pharmacy Advocacy Group Praises HELP Discussion Draft Bill, Offers Comments on Drug Pricing and PBM Transparency Recommendations
Washington, DC – In offering detailed comments today on the Health, Education, Labor and Pensions (HELP) Committee’s Bipartisan Discussion Draft Legislation to Reduce Health Care Costs, released by the full Committee on May 23, the Senior Care Pharmacy Coalition (SCPC) praised multiple provisions of the panel’s drug pricing and pharmacy benefit manager (PBM) transparency recommendations and also proposed modifications.
SCPC, the only Washington-based organization exclusively representing the interests of LTC pharmacies and their patients, respectfully urged the panel to consider the inclusion of a statutory federal definition of “long-term care (LTC) pharmacy” to better serve and protect the medication prerogatives of its elderly skilled nursing and assisted living facility (SNF/ALF)-based patient population.
“The Committee draft implicitly recognizes the labyrinthine and opaque business relationships between Prescription Drug Plans (PDPs), PBMs and their affiliated LTC, mail order and retail pharmacies through some of the proposed ‘controlled pharmacy’ provisions,” said Alan G. Rosenbloom, President and CEO of SCPC, in praising the draft. “The recommendations from Chairman Alexander, Ranking Member Murray and the full Committee are a thoughtful policy template with which to advance transparency, expand disclosure and help consumers.”
SCPC, in recommending the Committee consider adding a statutory definition of LTC pharmacy to the bill, noted there are substantial differences between the LTC patient population and the general population and between the clinical services provided by LTC pharmacies and those provided by retail or mail-order pharmacies for LTC patients. The HELP draft does not define pharmacies in general or LTC pharmacies in particular.
“We believe there are provisions of the draft that apply to providers which should also apply to LTC pharmacies as well,” observed Rosenbloom. “Since the draft does not define provider, pharmacies inadvertently could be excluded from these protections. This is yet another example of the need for a clear statutory definition of LTC pharmacy.” SCPC has developed draft legislation to accomplish this purpose.
####
The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies. Its members operate in all 50 states and serve 850,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.org to learn more.
Recent Posts
-
SCPC Applauds Bipartisan Group of Lawmakers Calling for Critical Changes to Medicare Drug Price Negotiations
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement commending Chairman Buddy Carter, Rep. Jake Auchincloss and other Members of Congress for urging HHS and CMS to examine the looming impact of Medicare drug price negotiations on America’s pharmacies.
-
SCPC Releases Statement in Support of Government Accountability Office (GAO) Report on the Inflation Reduction Act
SCPC has repeatedly warned about the impact of the Inflation Reduction Act’s (IRA) mandatory Medicare drug price negotiations on LTC pharmacies and the millions of vulnerable seniors they serve. We are glad the Government Accountability Office (GAO) is examining how these policies are affecting pharmacies, particularly LTC pharmacies, which already operate under a broken reimbursement model that often requires them to dispense many of the most commonly used medications at a loss.
-
SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs. “For far too long, pharmacy benefit managers (PBMs) have taken […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.